Is NCT03111459 recruiting in Cincinnati, OH?

Yes, NCT03111459 is currently recruiting participants at its Cincinnati, OH location. This thoracoabdominal aneurysm clinical trial is actively enrolling qualified participants.

How do I join the thoracoabdominal aneurysm clinical trial in Cincinnati?

To join this clinical trial in Cincinnati, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Cincinnati clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Thoracoabdominal Aneurysm Clinical Trial in Cincinnati, OH

About This Thoracoabdominal Aneurysm Study in Cincinnati

The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

Sponsor: The Christ Hospital

Who Can Participate

Inclusion Criteria

A patient may be entered into the study if the patient has at least one of the following:

an aneurysm with a maximum diameter of \> 5.5 cm or 2 times the normal diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements

aneurysm with a history of growth \> 0.5 cm in 6 months

saccular aneurysm deemed at significant risk for rupture

symptomatic aneurysm greater than 4.5 cm

Axillary or brachial and iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices or accessories, with or without use of a surgical conduit.

Proximal landing zone for the thoracic bifurcation stent graft that has:

≥ 2.5 cm of nonaneurysmal aortic segment including previously placed graft material (neck) distal to the left subclavian artery (LSA) diameter in the range of 26-42 mm.

adequate distance from the celiac artery, in order to accommodate cannulation from the antegrade access point when considering the total deployed length of the thoracic bifurcation and visceral manifold.

Minimum branch vessel diameter ≥ 5 mm.

Iliac artery or aortic distal fixation site, including both native tissue and previously placed graft, greater than or equal to 15 mm in length and diameter in the range of 8 - 25 mm.

Patient is ≥ 18 years of age.

Patient has a life expectancy \> 1 year.

Exclusion Criteria

Patient is a good candidate for and elects open surgical repair.

Patient can be treated in accordance with the instructions for use with a legally marketed endovascular prosthesis.

Patient is eligible for enrollment in a manufacturer-sponsored IDE at the investigational site.

Patient is unwilling to comply with the follow-up schedule.

Patient is unable or refuses to give informed consent.

Urgent or emergent presentation.

Patient is pregnant or breastfeeding.

Patient has a contained rupture.

Patient has a ruptured aneurysm.

Patient has a dissection in the treated portion of the aorta.

Obstructive stenting of any or all of the visceral vessels.

Poor performance status including 2 major system failures (cardiovascular, renal, hepatobiliary, neuromuscular). Medical Exclusion Criteria:

Patient has known sensitivities or allergies to the materials of construction of the devices, including nitinol (Nickel: Titanium), polyester, platinum-iridium, polytetrafluoroethylene (PTFE), platinum, gold, polyethylene, or stainless steel.

Patient has known hypersensitivity or contraindication to anticoagulation or contrast media that cannot be adequately medically managed.

Patient has an uncorrectable coagulopathy.

Patient has a body habitus that would inhibit x-ray visualization of the aorta or exceeds the safe capacity of the equipment.

Patient has had a major surgical or interventional procedure. unrelated to the treatment of the aneurysm planned \< 30 days of the endovascular repair.

Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina).

Patient has a systemic or local infection that may increase the risk of endovascular graft infection.

Baseline creatinine greater than 2.0 mg/dL.

History of connective tissue disorders (e.g., Marfan Syndrome, Ehler's Danlos Syndrome). Anatomical Exclusion Criteria:

Thrombus or excessive calcification within the neck of the aneurysm.

Anatomy that would not allow maintenance of at least one patent hypogastric artery.

Anatomy that would not allow primary or assisted patency of the left subclavian artery. Expanded Selection Criteria: Subjects who fail to meet inclusion criteria for the primary study arm may be enrolled under an expanded selection arm if they meet the following criteria. Inclusion Criteria:

Patient that meets the criteria for inclusion in the primary study arm but has one or more of the following criteria which would exclude them from the primary study arm:

Patient has a minimum branch vessel diameter less than 5 mm.

Patients presents urgently or emergently.

Patient has a contained rupture.

Patient has a ruptured aneurysm.

Patient has a type B dissection (subacute or chronic) in the portion of the aorta intended to be treated.

Patient has poor performance status including two major system failures (cardiovascular, pulmonary, renal, hepatobiliary, and neuromuscular).

Patient's baseline creatinine greater than 2.0 mg/dL.

Patient's anatomy that would not allow for maintenance of at least one hypogastric artery.

Patient's anatomy that would not allow for primary or assisted patency of the left subclavian artery. Or

Patient that meets the criteria for inclusion in the primary study arm and:

Would not be eligible for the primary study arm per a documented reason other than those outlined above, and

Per the opinion of the Principal Investigator, with concurrence of the IRB, alternative therapies are unsatisfactory and the probable risk of using the investigational device is no greater than the probable risk from the disease or condition.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT03111459) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thoracoabdominal Aneurysm Treatment Options in Cincinnati, OH

If you're searching for thoracoabdominal aneurysm treatment options in Cincinnati, OH, this clinical trial (NCT03111459) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thoracoabdominal aneurysm specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thoracoabdominal aneurysm clinical trials near you to find additional studies recruiting in your area.

Thoracoabdominal Aneurysm Clinical Trial in Cincinnati, OH

Expert Care in Cincinnati

IRB Approved

No-Cost Care

Apply for This Cincinnati Location

Why Participate?

Simple Process